Constitutive Siglec-1 expression confers susceptibility to HIV-1 infection of human dendritic cell precursors

Authors:

Abstract
The human dendritic cell (DC) lineage has recently been unraveled by high-dimensional mapping, revealing the existence of a discrete new population of blood circulating DC precursors (pre-DCs). Whether this new DC population possesses specific functional features as compared to the other blood DC subset upon pathogen encounter remained to be evaluated. A unique feature of pre-DCs among blood DCs is their constitutive expression of the viral adhesion receptor Siglec-1. Here, we show that pre-DCs, but not other blood DC subsets, are susceptible to infection by HIV-1 in a Siglec-1–dependent manner. Siglec-1 mediates pre-DC infection of CCR5- and CXCR4-tropic strains. Infection of pre-DCs is further enhanced in the presence of HIV-2/SIVmac Vpx, indicating that Siglec-1 does not counteract restriction factors such as SAMHD1. Instead, Siglec-1 promotes attachment and fusion of viral particles. HIV-1–infected pre-DCs produce new infectious viral particles that accumulate in intracellular compartments reminiscent of the virus-containing compartment of macrophages. Pre-DC activation by toll-like receptor (TLR) ligands induces an antiviral state that inhibits HIV-1 fusion and infection, but Siglec-1 remains functional and mediates replication-independent transfer of HIV-1 to activated primary T lymphocytes. Altogether, Siglec-1–mediated susceptibility to HIV-1 infection of pre-DCs constitutes a unique functional feature that might represent a preferential relationship of this emerging cell type with viruses.
All Related Versions
Funding Information
  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales (AAP15 18046)
  • Sidaction (2018-1-AEQ-11984)
  • Fondation pour la Recherche Médicale (Financement Jeune Chercheur)
  • Agence Nationale de la Recherche (ANR-10-IDEX-0001-02 PSL)
  • Agence Nationale de la Recherche (ANR-11-LABX-0043)
  • Agency for Science, Technology and Research (Singapore Immunology Network (SIgN) core funding)
  • Sidaction (2018-1-FJC-11566)

This publication has 51 references indexed in Scilit: